Michael H. Kroll, MD

Professor of Medicine, Chief of the Section of Benign Hematology University of Texas MD Anderson Cancer Center

Should I have concerns about using an oral thrombin inhibitor in a patient with recurrent DVT? Sunday, February 1st, 2015
This month, Michael H. Kroll, MD, advises on switching a patient with a history of deep-vein thrombosis (DVT) from warfarin to an oral thrombin inhibitor.